Lab-Scale Oligonucleotide Purification Using Waters Fraction Manager — Analytical System

Significance of the Topic

The purification of synthetic oligonucleotides is a critical step for ensuring product safety and efficacy, especially in therapeutic applications such as siRNA gene silencing. Impurities from incomplete coupling or synthesis by-products can reduce potency or cause off-target effects, making efficient analytical-scale purification methods essential for research and development.

Objectives and Study Overview

The primary goal was to evaluate the Waters Fraction Manager–Analytical (WFM-A) as an integrated UPLC fraction collection system capable of isolating and enriching therapeutic oligonucleotides from process-related impurities. The study used a commercially synthesized 21-mer siRNA to demonstrate purity enhancement and workflow efficiency.

Methodology and Instrumentation

Methodology:

• Two consecutive 1 nmol injections of a 21-mer siRNA sample were separated using a 10-minute gradient (5% to 13% organic) on a C18 column.
• Collection window programmed from 9.16 to 9.76 minutes based on processed chromatogram data.
• Collected fractions dried by vacuum centrifugation and reconstituted to the original concentration for comparison.

Instrumentation Used:

• Waters UPLC system equipped with the Fraction Manager–Analytical (WFM-A).
• Empower Chromatography Data Software for automated fraction collection control (time, slope, threshold events).
• Waters OST BEH C18 Column, 130 Å, 1.7 μm, 2.1 × 50 mm.
• Mobile phase A: 15 mM butylamine and 50 mM hexafluoro-isopropanol (HFIP) in water.
• Mobile phase B: 15 mM butylamine and 50 mM HFIP in methanol.

Main Results and Discussion

The WFM-A enabled the isolation of the parent 21-mer siRNA with high purity and recovery. Starting from a commercial sample with approximately 81% maximum theoretical purity, the fraction-collected material achieved greater than 97% purity under equivalent mass-load conditions. The system demonstrated minimal carryover and efficient collection of narrow chromatographic peaks, highlighting its suitability for analytical-scale purification tasks.

Benefits and Practical Applications

The WFM-A provides:

• High-purity analyte isolation from complex oligonucleotide mixtures.
• Seamless integration into existing UPLC workflows without extensive modifications.
• Automated fraction collection with precise control over timing, slope, and threshold parameters.
• Improved laboratory throughput through rapid method setup and reduced manual intervention.

These features support applications in therapeutic development, quality control, and research requiring enriched oligonucleotide samples.

Future Trends and Opportunities

Potential developments include:

• Scaling workflows for preparative-scale oligonucleotide purification.
• Adapting fraction collection strategies for other biomolecules, such as peptides or small nucleic acid constructs.
• Integration with mass spectrometry detectors for real-time fraction quality assessment.
• Advanced software algorithms for dynamic collection event optimization based on live chromatographic data.

Conclusion

The Waters Fraction Manager–Analytical system offers an effective analytical-scale solution for isolating and enriching therapeutic oligonucleotides. It enhances sample purity, integrates readily with standard UPLC platforms, and streamlines workflows, making it a valuable tool for pharmaceutical research and quality control.

References

1. McCarthy S., Gilar M., Gebler J. Reversed-phase ion-pair liquid chromatography analysis and purification of small interfering RNA. Analytical Biochemistry. 2009;390:181–188.
2. Birdsall R., Yu Y.Q. High-throughput screening of oligonucleotides for identity and purity assessment using the ACQUITY QDa Detector and ProMass for MassLynx. 2016;720005681EN.
3. Aubin A., Jablonski J. Small scale peptide and impurity isolation using the ACQUITY UPLC H-Class and Waters Fraction Manager – Analytical Systems. 2015;720005500EN.